U.S. Personal Products Stock News

Rhythm Pharmaceuticals (NasdaqGM:RYTM) has published a new evidence-based diagnostic algorithm for Bardet-Biedl syndrome. The algorithm is designed to streamline and accelerate clinical diagnosis of this rare obesity disorder. The update incorporates recent advances in genetic testing to support earlier and more accurate identification of BBS. Rhythm Pharmaceuticals focuses on treatments for rare genetic forms of obesity, and Bardet-Biedl syndrome is a core part of that remit. A clearer...

Park Aerospace (PKE) has capped FY 2026 with fourth quarter revenue of US$24.2 million and basic EPS of US$0.19, set against a trailing twelve month EPS of US$0.56 that reflects 91.1% earnings growth over the last year. Over recent quarters, revenue has moved from US$16.9 million in Q4 FY 2025 to US$24.2 million in Q4 FY 2026, while basic EPS has shifted from US$0.06 to US$0.19, alongside trailing twelve month net profit margins rising from 9.5% to 15.4%. For investors, this combination of...

Here we explore whether Photronics at US$32.34 still offers value after a strong run, or whether most of the opportunity is already priced in. The stock is up 93.5% over the past year, even though it has fallen 37.2% over the last week, 32.3% over the past month, and is down 3.2% year to date. These moves can influence how you think about both risk and potential upside. Recent headlines around semiconductor demand, capacity build outs, and renewed interest in chip supply chains help frame...

PagerDuty Q1 2027 earnings snapshot PagerDuty (PD) opened its new fiscal year with Q1 2027 revenue of US$121 million and basic EPS of US$0.13, alongside net income excluding extra items of US$10.2 million. The company has seen quarterly revenue move from US$119.8 million in Q1 2026 to a range between US$123.4 million and US$124.8 million through the rest of 2026. Basic EPS shifted from a loss of US$0.07 in Q1 2026 to US$1.72 at its Q3 peak and US$0.13 in the latest quarter. Overall, margins...

If you are wondering whether Navan at US$21.37 is offering good value or asking too much, you are in the right place. The stock has returned 7.5% over the last 7 days, 24.8% over the last 30 days, and 31.5% year to date, which can change how you think about both upside potential and risk. Recent coverage has focused on Navan's position within the consumer services space and how investors are reacting to its latest corporate updates, including product and platform developments. This context...

If you are wondering whether Patterson-UTI Energy stock still offers value at around US$11.21 per share, this breakdown is designed to help you judge that for yourself. The stock has pulled back around 9.0% over the past week and 9.3% over the past month, even after recording a 73.2% gain year to date and a 114.3% return over the past year. Recent coverage has focused on Patterson-UTI Energy in the context of the wider Energy Services sector. This has included how its share performance...

Old National Bancorp appointed Shane Print as President of Commercial & Industrial Banking. Print will lead the company’s C&I Banking business following the retirement of his predecessor. The move focuses leadership attention on growth in a key business area for NasdaqGS:ONB. Old National Bancorp, trading on NasdaqGS:ONB, is putting fresh leadership in place over a core lending segment with Shane Print now heading Commercial & Industrial Banking. The appointment comes with the stock at...

Nextpower (NasdaqGS:NXT) has entered a definitive agreement to acquire Prevalon Energy. The deal expands Nextpower beyond solar hardware into battery energy storage systems and intelligent energy management software. The acquisition targets critical infrastructure customers, including AI data centers and utilities. Nextpower, trading at $156.51, has seen sharp share price moves recently, with the stock up 19.9% over the past week and 37.0% over the past month. Returns of 68.7% year to date...

If you are wondering whether Nucor stock still offers value at current levels, the key is understanding what the recent share price is actually pricing in. The stock last closed at US$250.00, with returns of 7.8% over 7 days, 12.4% over 30 days, 47.6% year to date and 132.1% over 1 year. This naturally raises questions about how much upside or downside may be left. Recent coverage of Nucor has focused on its position within the broader materials sector and how investor sentiment around steel...

State Street plans to close and liquidate the State Street DoubleLine Emerging Markets Fixed Income ETF (EMTL). Final trading in EMTL is expected to occur in July 2026, after which the fund will be liquidated. The decision affects existing EMTL shareholders and adds a fresh data point to how State Street manages its ETF lineup. For investors watching State Street (NYSE:STT), this move comes as the stock trades at $155.64, with a reported return of 20.6% year to date and 66.2% over the past...

Board moves and dividend change put Lennox International (LII) in focus Lennox International (LII) is back on investors’ radar after a quarterly report that beat revenue expectations, a higher quarterly dividend, and a board reshuffle that reduced director seats from nine to eight. See our latest analysis for Lennox International. Lennox International’s recent revenue beat, dividend increase and board changes come after a mixed period for the stock. The share price is down about 12% over...

ePlus (PLUS) closed out FY 2026 with fourth quarter revenue of US$581.6 million and basic EPS of US$0.97, setting the stage for investors to reassess how the business is trending into the new year. The company has seen quarterly revenue move from US$498.1 million in Q4 FY 2025 to US$581.6 million in Q4 FY 2026, while basic EPS in those periods came in at US$0.96 and US$0.97 respectively. Over the last 12 months, net income excluding extra items totaled US$124.1 million on revenue of US$2.4...

Wondering if NetApp at US$174.29 is still offering value after a strong run, or if expectations have already been priced in? This article focuses squarely on what the current share price implies. The stock has posted returns of 25.1% over the past week, 60.4% over the past month, 63.7% year to date and 79.2% over the last year, with longer term figures of 161.3% over three years and 142.6% over five years that many investors will want to put into context. Recent market conversation around...

Wondering if BNY is still worth a closer look after its run, or if most of the value is already reflected in the share price? This article breaks down what the current price might be implying. Bank of New York Mellon Corporation's stock recently closed at US$139.43, with returns of 0.2% over 7 days, 5.4% over 30 days, 19.1% year to date and 60.3% over the last year. The 3 year return is around 3x and the 5 year return is just over 2x. Recent headlines around BNY have focused on its role as a...

Universal (NYSE:UVV) FY 2026 Earnings Snapshot Universal (NYSE:UVV) closed out FY 2026 with Q4 revenue of US$715.2 million and a reported loss per share of US$1.73, as investors weighed these headline figures against full year trends. Over the past six quarters, revenue has moved between US$593.8 million and US$937.2 million per quarter, while quarterly EPS ranged from US$0.34 to US$2.39 before this latest loss. This gives you a wide band of outcomes to factor into your view on the stock...

Wondering whether Huntington Ingalls Industries, at around US$308 a share, still offers value or if most of the opportunity has already been priced in. The stock is down 3.9% over the past week and 14.9% over the past month, yet it still shows a 40.5% return over 1 year and 58.2% over 3 years, which can change how you think about both risk and opportunity. Recent coverage has focused on Huntington Ingalls Industries as a key US defense contractor, with attention on its role in major long...

Q1 2027 earnings set the stage Okta (OKTA) has just opened Q1 2027 with revenue of US$765 million and basic EPS of US$0.42, putting fresh numbers behind a year in which trailing EPS reached US$1.40 on US$3.0 billion of revenue and net income of US$247 million. Over the past six reported quarters, revenue has moved from US$682 million in Q4 2025 to US$765 million in Q1 2027, while quarterly basic EPS has ranged between US$0.13 and US$0.42. This gives investors a clearer picture of how profit...

Wondering if Eastman Chemical at around US$75.87 is offering real value or just fair pricing? This article walks through what the numbers say about the stock. The share price return sits at 2.4% over the past week, 7.7% over the past month, 17.9% year to date and 1.6% over the past year, against a longer-term picture that includes a 3.5% return over three years and a decline of 29.7% over five years. Recent coverage has focused on Eastman Chemical's role as a diversified materials producer,...

Wondering whether Coursera at US$5.39 is starting to look like value, or if the stock still carries more risk than reward. The share price has inched up about 1.3% over the last week, but is still down about 11.8% over the past month, 23.9% year to date and 39.1% over the last year, which may catch the eye of investors looking for a reset opportunity. Recent headlines have focused on Coursera's position as a major online learning platform and its role in digital upskilling partnerships. This...

Wondering whether Live Oak Bancshares at around US$38.03 is offering fair value right now, or if the recent price puts it out of your comfort zone? The stock has returned 2.0% over the past week, 0.6% over the last month, 9.6% year to date and 39.0% over the past year, while the 5 year return shows a decline of 32.9%. These moves have come as Live Oak Bancshares continues to attract attention in the US regional banking space, with investors watching how its lending focus and digital platform...

TG Therapeutics reported positive Phase 3 ENHANCE results for BRIUMVI, confirming a single 600 mg Day 1 infusion is bioequivalent to the current two-infusion initiation regimen for multiple sclerosis. The simplified regimen is intended to reduce treatment burden for patients and infusion centers while maintaining safety and efficacy outcomes seen in the trial. The company plans to submit these data to regulators, aiming to update the BRIUMVI label pending review and approval. For investors...

Cadence Design Systems (NasdaqGS:CDNS) and Samsung Foundry agreed a multi-year expansion of their collaboration around second-generation 2nm process technology. The deal covers a broad Memory and Interface IP portfolio and certification of Cadence's AI focused design and analysis flows across Samsung's next generation 2nm and 3D IC platforms. The partnership targets next generation AI infrastructure and hardware, aiming to provide a more complete platform for advanced chip design. For...

Trustmark (NasdaqGS:TRMK) announced the retirement of Wayne A. Stevens as President of Retail Banking. Stevens concludes a career of more than four decades with the company, including service as an executive officer since 2009. The change affects leadership of one of Trustmark’s core business areas, retail banking. For a regional financial institution like Trustmark, retail banking sits at the heart of its business model, connecting deposit customers, consumer lending and local branch...

Intuitive Surgical (NasdaqGS:ISRG) is rolling out more than 100 upgrades to its da Vinci 5 robotic surgery platform, including extended-use Force Feedback instruments aimed at reducing per procedure costs. The company has also promoted Taylor Patton to Chief Commercial and Marketing Officer, positioning her to lead global commercialization efforts for da Vinci 5 and other platforms. For anyone following surgical robotics, Intuitive Surgical sits at the center of one of the most closely...